HYAL decision highlights importance of relevant public in assessing registrability

European Union

The General Court confirmed that the relevant public, which consisted of professionals, would understand Fidia farmaceutici's mark HYAL as a direct reference to hyaluronic acid.

Get unlimited access to all WTR content